Literature DB >> 26827942

Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders.

Nader H Moniri1.   

Abstract

Over the last decade, a subfamily of G protein-coupled receptors that are agonized by endogenous and dietary free-fatty acids (FFA) has been discovered. These free-fatty acid receptors include FFA2 and FFA3, which are agonized by short-chained FFA, as well as FFA1 and FFA4, which are agonized by medium-to-long chained FFA. Ligands for FFA1 and FFA4 comprise the family of long chain polyunsaturated omega-3 fatty acids including α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), suggesting that many of the long-known beneficial effects of these fats may be receptor mediated. In this regard, FFA4 has gathered considerable interest due to its role in ameliorating inflammation, promoting insulin sensitization, and regulating energy metabolism in response to FFA ligands. The goal of this review is to summarize the body of evidence in regard to FFA4 signal transduction, its mechanisms of regulation, and its functional role in a variety of tissues. In addition, recent endeavors toward discovery of small molecules that modulate FFA4 activity are also presented.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Free fatty acids; Free-fatty acid receptor-4; G protein-coupled receptors; GPR120; Polyunsaturated fats

Mesh:

Substances:

Year:  2016        PMID: 26827942      PMCID: PMC6415295          DOI: 10.1016/j.bcp.2016.01.021

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  24 in total

1.  Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates β-Arrestin Recruitment and Signaling to ERK1/2.

Authors:  Ilya S Senatorov; Ameneh Cheshmehkani; Rebecca N Burns; Kirti Singh; Nader H Moniri
Journal:  Mol Pharmacol       Date:  2020-03-04       Impact factor: 4.436

2.  Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.

Authors:  Neha Milind Chitre; Bo Jarrett Wood; Azizi Ray; Nader H Moniri; Kevin Sean Murnane
Journal:  Neuropharmacology       Date:  2020-01-27       Impact factor: 5.250

3.  Eicosapentaenoic Acid Potentiates Brown Thermogenesis through FFAR4-dependent Up-regulation of miR-30b and miR-378.

Authors:  Jiyoung Kim; Meshail Okla; Anjeza Erickson; Timothy Carr; Sathish Kumar Natarajan; Soonkyu Chung
Journal:  J Biol Chem       Date:  2016-08-03       Impact factor: 5.157

4.  Spatiotemporal dynamic monitoring of fatty acid-receptor interaction on single living cells by multiplexed Raman imaging.

Authors:  Wei Zhang; Fangjun Lin; Yan Liu; Han Zhang; Timothy A Gilbertson; Anhong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-03       Impact factor: 11.205

5.  Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal β-arrestin phosphosensor in Raw 264.7 macrophages.

Authors:  Ameneh Cheshmehkani; Ilya S Senatorov; Jyothi Dhuguru; Ola Ghoneim; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2017-09-21       Impact factor: 5.858

6.  Effect of propolis phenolic compounds on free fatty acid receptor 4 activation.

Authors:  Hyunnho Cho; Kyong Kim; Nayeon Kim; Minji Woo; Hye Young Kim
Journal:  Food Sci Biotechnol       Date:  2019-10-14       Impact factor: 2.391

Review 7.  The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.

Authors:  Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

Review 8.  GPR120: a critical role in adipogenesis, inflammation, and energy metabolism in adipose tissue.

Authors:  Tongxing Song; Yang Yang; Yuanfei Zhou; Hongkui Wei; Jian Peng
Journal:  Cell Mol Life Sci       Date:  2017-03-11       Impact factor: 9.261

9.  GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.

Authors:  Gabriele Carullo; Sarah Mazzotta; Margarita Vega-Holm; Fernando Iglesias-Guerra; José Manuel Vega-Pérez; Francesca Aiello; Antonella Brizzi
Journal:  J Med Chem       Date:  2021-04-10       Impact factor: 7.446

Review 10.  Anti-Atherosclerotic Potential of Free Fatty Acid Receptor 4 (FFAR4).

Authors:  Anna Kiepura; Kamila Stachyra; Rafał Olszanecki
Journal:  Biomedicines       Date:  2021-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.